GSA Capital Partners’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-129,422
Closed -$676K 2023
2025
Q3
$676K Buy
129,422
+48,860
+61% +$186K 0.06% 649
2025
Q2
$279K Buy
80,562
+28,083
+54% +$83.5K 0.02% 1304
2025
Q1
$137K Sell
52,479
-77,469
-60% -$304K 0.01% 1468
2024
Q4
$535K Buy
129,948
+114,541
+743% +$623K 0.04% 841
2024
Q3
$109K Sell
15,407
-82,997
-84% -$620K 0.01% 1480
2024
Q2
$642K Buy
98,404
+70,983
+259% +$485K 0.04% 802
2024
Q1
$228K Buy
27,421
+5,499
+25% +$53.6K 0.02% 1347
2023
Q4
$241K Sell
21,922
-90,179
-80% -$761K 0.02% 1229
2023
Q3
$943K Buy
112,101
+52,712
+89% +$567K 0.08% 432
2023
Q2
$746K Buy
+59,389
New +$739K 0.07% 482
2022
Q3
Sell
-178,593
Closed -$2.99M 1813
2022
Q2
$2.99M Buy
+178,593
New +$3.83M 0.45% 2

Other funds holding RLAY